Skip to main content

Main menu

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Instructions for authors
  • About the journal
    • About the journal
    • Editorial board
    • Instructions for authors
    • FAQs
    • Chinese Stroke Association
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
  • BMJ Journals

User menu

  • Login

Search

  • Advanced search
  • BMJ Journals
  • Login
  • Facebook
  • Twitter
Stroke and Vascular Neurology

Advanced Search

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Instructions for authors
  • About the journal
    • About the journal
    • Editorial board
    • Instructions for authors
    • FAQs
    • Chinese Stroke Association
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
Open Access

Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial

Jie Xu, Yilong Wang, Anxin Wang, Zhiqiang Gao, Xiaoping Gao, Huisheng Chen, Junshan Zhou, Xingquan Zhao, Yongjun Wang
DOI: 10.1136/svn-2018-000221 Published 23 September 2019
Jie Xu
1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jie Xu
Yilong Wang
1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anxin Wang
1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anxin Wang
Zhiqiang Gao
3 Department of Neurology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoping Gao
4 Department of Neurology, The First Affiliated Hospital of Hunan Normal University, Changsha, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huisheng Chen
5 Department of Neurology, General Hospital, PLA Shenyang Military Region, Shenyang, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Huisheng Chen
Junshan Zhou
6 Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xingquan Zhao
1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yongjun Wang
1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 China National Clinical Research Center for Neurological Diseases, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yongjun Wang
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 4 no. 3 109-114
DOI 
https://doi.org/10.1136/svn-2018-000221
PubMed 
31709115

Print ISSN 
2059-8688
Online ISSN 
2059-8696
History 
  • Received December 29, 2018
  • Revised February 20, 2019
  • Accepted February 25, 2019
  • Published online September 23, 2019.

Article Versions

  • Previous version (April 22, 2019 - 23:06).
  • Previous version (April 26, 2019 - 07:48).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Author Information

  1. Jie Xu1,2,
  2. Yilong Wang1,2,
  3. Anxin Wang1,2,
  4. Zhiqiang Gao3,
  5. Xiaoping Gao4,
  6. Huisheng Chen5,
  7. Junshan Zhou6,
  8. Xingquan Zhao1,2,
  9. Yongjun Wang1,2
  1. 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  2. 2 China National Clinical Research Center for Neurological Diseases, Beijing, China
  3. 3 Department of Neurology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
  4. 4 Department of Neurology, The First Affiliated Hospital of Hunan Normal University, Changsha, China
  5. 5 Department of Neurology, General Hospital, PLA Shenyang Military Region, Shenyang, China
  6. 6 Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
  1. Correspondence to Prof. Xingquan Zhao; zxq{at}vip.163.com and Professor Yongjun Wang; yongjunwang{at}ncrcnd.org.cn
View Full Text

Article usage

Article usage: April 2019 to May 2025

AbstractFullPdf
Apr 201913012838
May 201919317355
Jun 201913513317
Jul 201911611512
Aug 2019404016
Sep 2019828119
Oct 2019949134
Nov 2019949442
Dec 2019868138
Jan 2020575537
Feb 2020545026
Mar 2020464632
Apr 202031299
May 2020363611
Jun 2020484621
Jul 2020545522
Aug 2020595735
Sep 2020524522
Oct 2020444115
Nov 2020696539
Dec 2020635429
Jan 2021706757
Feb 2021958375
Mar 2021928949
Apr 2021594843
May 2021797944
Jun 2021585641
Jul 2021555229
Aug 2021686650
Sep 2021444027
Oct 2021938765
Nov 2021938953
Dec 2021706839
Jan 202221521647
Feb 2022808049
Mar 2022848674
Apr 2022837843
May 2022736943
Jun 2022767943
Jul 2022615530
Aug 2022868354
Sep 2022676537
Oct 202210310060
Nov 202210310158
Dec 2022726932
Jan 2023363429
Feb 20231059846
Mar 2023948951
Apr 2023798248
May 2023776649
Jun 2023595530
Jul 2023888251
Aug 2023988942
Sep 202311911334
Oct 202318117647
Nov 202331230946
Dec 202314912668
Jan 202411010457
Feb 202418211461
Mar 2024236223186
Apr 202415514999
May 202428327570
Jun 20241099856
Jul 202416815663
Aug 202411911273
Sep 2024173152108
Oct 2024148154116
Nov 2024796739
Apr 20254323
May 20252150

Statistics from Altmetric.com

PreviousNext
Back to top
Vol 4 Issue 3 Table of Contents
Stroke and Vascular Neurology: 4 (3)
  • Table of Contents
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on Stroke and Vascular Neurology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
(Your Name) has sent you a message from Stroke and Vascular Neurology
(Your Name) thought you would like to see the Stroke and Vascular Neurology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
Jie Xu, Yilong Wang, Anxin Wang, Zhiqiang Gao, Xiaoping Gao, Huisheng Chen, Junshan Zhou, Xingquan Zhao, Yongjun Wang
Stroke and Vascular Neurology Sep 2019, 4 (3) 109-114; DOI: 10.1136/svn-2018-000221

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Cite This
  • APA
  • Chicago
  • Endnote
  • MLA
Loading
Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
Jie Xu, Yilong Wang, Anxin Wang, Zhiqiang Gao, Xiaoping Gao, Huisheng Chen, Junshan Zhou, Xingquan Zhao, Yongjun Wang
Stroke and Vascular Neurology Sep 2019, 4 (3) 109-114; DOI: 10.1136/svn-2018-000221
Download PDF

Share
Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
Jie Xu, Yilong Wang, Anxin Wang, Zhiqiang Gao, Xiaoping Gao, Huisheng Chen, Junshan Zhou, Xingquan Zhao, Yongjun Wang
Stroke and Vascular Neurology Sep 2019, 4 (3) 109-114; DOI: 10.1136/svn-2018-000221
Reddit logo Twitter logo Facebook logo Mendeley logo
Respond to this article
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Lower lymphocyte to monocyte ratio is a potential predictor of poor outcome in patients with cerebral venous sinus thrombosis
  • Flow diversion covering the M1 origin as a last resort
  • Shenzhen stroke emergency map improves access to rt-PA for patients with acute ischaemic stroke
Show more Original article

Similar Articles

 
 

CONTENT

  • Latest content
  • Current issue
  • Archive
  • eLetters
  • Sign up for email alerts
  • RSS

JOURNAL

  • About the journal
  • Editorial board
  • Recommend to librarian
  • Chinese Stroke Association

AUTHORS

  • Instructions for authors
  • Submit a paper
  • Track your article
  • Open Access at BMJ

HELP

  • Contact us
  • Reprints
  • Permissions
  • Advertising
  • Feedback form

© 2025 Chinese Stroke Association